JAGX: Jaguar Health Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Jaguar Health Inc (JAGX).
$11.92M Market Cap.
JAGX Market Cap. (MRY)
JAGX Shares Outstanding (MRY)
JAGX Assets (MRY)
Total Assets
$53.42M
Total Liabilities
$44.45M
Total Investments
$0
JAGX Income (MRY)
Revenue
$11.69M
Net Income
-$38.49M
Operating Expense
$40.56M
JAGX Cash Flow (MRY)
CF Operations
-$29.38M
CF Investing
-$231.00K
CF Financing
$31.20M
JAGX Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $53,425,000 (5.24%) | $50,763,000 (6.98%) | $47,449,000 (-10.92%) | $53,265,000 (24.33%) |
Assets Current | $32,198,000 (15.15%) | $27,963,000 (25.28%) | $22,321,000 (-21.50%) | $28,434,000 (59.81%) |
Assets Non-Current | $21,227,000 (-6.90%) | $22,800,000 (-9.26%) | $25,128,000 (1.20%) | $24,831,000 (-0.88%) |
Goodwill & Intangible Assets | $18,479,000 (-8.14%) | $20,116,000 (-10.35%) | $22,439,000 (-0.94%) | $22,651,000 (-6.93%) |
Shareholders Equity | $7,285,000 (46.85%) | $4,961,000 (851.67%) | -$660,000 (-105.68%) | $11,611,000 (-32.50%) |
Property Plant & Equipment Net | $1,400,000 (-16.27%) | $1,672,000 (-1.47%) | $1,697,000 (-2.13%) | $1,734,000 (156.13%) |
Cash & Equivalents | $8,002,000 (23.70%) | $6,469,000 (18.28%) | $5,469,000 (-67.93%) | $17,051,000 (110.77%) |
Accumulated Other Comprehensive Income | -$467,000 (28.37%) | -$652,000 (4.12%) | -$680,000 (0%) | $0 (0%) |
Deferred Revenue | $723,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $10,345,000 (12.58%) | $9,189,000 (30.82%) | $7,024,000 (43.35%) | $4,900,000 (76.13%) |
Trade & Non-Trade Receivables | $1,647,000 (-24.59%) | $2,184,000 (-11.47%) | $2,467,000 (15.07%) | $2,144,000 (-52.98%) |
Trade & Non-Trade Payables | $5,286,000 (6.27%) | $4,974,000 (-14.36%) | $5,808,000 (17.83%) | $4,929,000 (3.57%) |
Accumulated Retained Earnings (Deficit) | -$346,482,000 (-12.40%) | -$308,248,000 (-15.47%) | -$266,949,000 (-21.62%) | -$219,494,000 (-31.51%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $36,526,000 (-1.53%) | $37,094,000 (6.48%) | $34,835,000 (18.63%) | $29,365,000 (81.15%) |
Debt Current | $12,337,000 (136.57%) | $5,215,000 (-68.14%) | $16,366,000 (377.98%) | $3,424,000 (-9.63%) |
Debt Non-Current | $24,189,000 (-24.12%) | $31,879,000 (72.61%) | $18,469,000 (-28.80%) | $25,941,000 (108.85%) |
Total Liabilities | $44,446,000 (-3.10%) | $45,866,000 (-6.03%) | $48,808,000 (17.86%) | $41,412,000 (61.51%) |
Liabilities Current | $19,704,000 (40.87%) | $13,987,000 (-53.90%) | $30,339,000 (96.10%) | $15,471,000 (17.03%) |
Liabilities Non-Current | $24,742,000 (-22.39%) | $31,879,000 (72.61%) | $18,469,000 (-28.80%) | $25,941,000 (108.85%) |
JAGX Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $11,689,000 (19.75%) | $9,761,000 (-18.36%) | $11,956,000 (175.80%) | $4,335,000 (-53.81%) |
Cost of Revenue | $1,955,000 (-4.03%) | $2,037,000 (0.89%) | $2,019,000 (-13.46%) | $2,333,000 (-28.87%) |
Selling General & Administrative Expense | $24,023,000 (4.23%) | $23,048,000 (-13.69%) | $26,705,000 (2.72%) | $25,997,000 (23.82%) |
Research & Development Expense | $16,542,000 (-11.05%) | $18,596,000 (5.38%) | $17,647,000 (17.03%) | $15,079,000 (135.13%) |
Operating Expenses | $40,565,000 (-3.45%) | $42,015,000 (-5.27%) | $44,352,000 (3.84%) | $42,710,000 (30.40%) |
Interest Expense | $231,000 (-96.38%) | $6,382,000 (-49.84%) | $12,723,000 (51.09%) | $8,421,000 (201.61%) |
Income Tax Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$39,251,000 (6.32%) | -$41,901,000 (13.42%) | -$48,395,000 (7.99%) | -$52,600,000 (-55.58%) |
Net Income to Non-Controlling Interests | -$759,000 (-26.29%) | -$601,000 (36.13%) | -$941,000 (-18720.00%) | -$5,000 (0%) |
Net Income | -$38,492,000 (6.80%) | -$41,300,000 (12.97%) | -$47,454,000 (9.77%) | -$52,595,000 (-55.57%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$38,492,000 (6.80%) | -$41,300,000 (12.97%) | -$47,454,000 (9.77%) | -$52,595,000 (-36.09%) |
Weighted Average Shares | $294,534 (-98.72%) | $23,068,423 (1658.91%) | $1,311,519 (120.00%) | $596,154 (247.12%) |
Weighted Average Shares Diluted | $294,534 (-98.72%) | $23,068,423 (1658.91%) | $1,311,519 (120.00%) | $596,154 (247.12%) |
Earning Before Interest & Taxes (EBIT) | -$38,261,000 (-9.57%) | -$34,918,000 (-0.54%) | -$34,731,000 (21.38%) | -$44,174,000 (-42.42%) |
Gross Profit | $9,734,000 (26.02%) | $7,724,000 (-22.27%) | $9,937,000 (396.35%) | $2,002,000 (-67.21%) |
Operating Income | -$30,831,000 (10.09%) | -$34,291,000 (0.36%) | -$34,415,000 (15.46%) | -$40,708,000 (-52.77%) |
JAGX Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | -$231,000 (0%) | $0 (0%) | -$1,675,000 (-27816.67%) | -$6,000 (14.29%) |
Net Cash Flow from Financing | $31,202,000 (-8.84%) | $34,227,000 (47.65%) | $23,181,000 (-47.24%) | $43,937,000 (125.41%) |
Net Cash Flow from Operations | -$29,384,000 (11.61%) | -$33,242,000 (-0.42%) | -$33,104,000 (5.34%) | -$34,970,000 (-128.89%) |
Net Cash Flow / Change in Cash & Cash Equivalents | $1,533,000 (53.30%) | $1,000,000 (108.63%) | -$11,582,000 (-229.25%) | $8,961,000 (113.00%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Capital Expenditure | -$16,000 (0%) | $0 (0%) | -$1,675,000 (-27816.67%) | -$6,000 (14.29%) |
Issuance (Repayment) of Debt Securities | -$708,000 (25.71%) | -$953,000 (-135.05%) | $2,719,000 (-66.47%) | $8,110,000 (-32.77%) |
Issuance (Purchase) of Equity Shares | $31,910,000 (-4.28%) | $33,336,000 (62.92%) | $20,462,000 (-39.07%) | $33,581,000 (332.97%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | -$54,000 (-460.00%) | $15,000 (-6.25%) | $16,000 (0%) | $0 (0%) |
Share Based Compensation | $1,641,000 (-22.30%) | $2,112,000 (-36.35%) | $3,318,000 (-16.51%) | $3,974,000 (40.72%) |
Depreciation Amortization & Accretion | $2,358,000 (-1.26%) | $2,388,000 (4.19%) | $2,292,000 (26.42%) | $1,813,000 (-20.48%) |
JAGX Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | 83.30% (5.31%) | 79.10% (-4.81%) | 83.10% (79.87%) | 46.20% (-29.03%) |
Profit Margin | -329.30% (22.17%) | -423.10% (-6.60%) | -396.90% (67.29%) | -1213.30% (-194.63%) |
EBITDA Margin | -307.20% (7.83%) | -333.30% (-22.85%) | -271.30% (72.24%) | -977.20% (-219.14%) |
Return on Average Equity (ROAE) | -309.20% (63.86%) | -855.60% (38.03%) | -1380.70% (-535.68%) | -217.20% (53.93%) |
Return on Average Assets (ROAA) | -67.30% (16.40%) | -80.50% (14.54%) | -94.20% (-12.28%) | -83.90% (18.62%) |
Return on Sales (ROS) | -327.30% (8.50%) | -357.70% (-23.13%) | -290.50% (71.49%) | -1019.00% (-208.32%) |
Return on Invested Capital (ROIC) | -92.70% (7.02%) | -99.70% (26.26%) | -135.20% (7.65%) | -146.40% (-101.33%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -0.19 (-127.06%) | -0.09 (52.78%) | -0.18 (79.64%) | -0.88 (-8.47%) |
Price to Sales Ratio (P/S) | 0.64 (77.65%) | 0.36 (-49.93%) | 0.71 (-93.33%) | 10.73 (219.64%) |
Price to Book Ratio (P/B) | 1.64 (5.62%) | 1.55 (108.10%) | -19.12 (-542.87%) | 4.32 (-0.14%) |
Debt to Equity Ratio (D/E) | 6.1 (-34.01%) | 9.24 (112.50%) | -73.95 (-2173.23%) | 3.57 (139.24%) |
Earnings Per Share (EPS) | -130.69 (-7201.12%) | -1.79 (95.05%) | -36.18 (58.99%) | -88.22 (60.79%) |
Sales Per Share (SPS) | 39.69 (9282.03%) | 0.42 (-95.36%) | 9.12 (25.36%) | 7.27 (-86.69%) |
Free Cash Flow Per Share (FCFPS) | -99.82 (-6827.06%) | -1.44 (94.57%) | -26.52 (54.80%) | -58.67 (34.08%) |
Book Value Per Share (BVPS) | 24.73 (11404.19%) | 0.21 (142.74%) | -0.5 (-102.58%) | 19.48 (-80.55%) |
Tangible Assets Book Value Per Share (TABVPS) | 118.65 (8827.61%) | 1.33 (-93.03%) | 19.07 (-62.87%) | 51.35 (-52.34%) |
Enterprise Value Over EBIT (EV/EBIT) | -1 (0.00%) | -1 (0.00%) | -1 (0.00%) | -1 (66.67%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -0.92 (25.45%) | -1.23 (-14.10%) | -1.08 (30.36%) | -1.55 (46.06%) |
Asset Turnover | 0.2 (7.37%) | 0.19 (-19.83%) | 0.24 (243.48%) | 0.07 (-72.40%) |
Current Ratio | 1.63 (-18.26%) | 2 (171.60%) | 0.74 (-59.96%) | 1.84 (36.55%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$29,400,000 (11.56%) | -$33,242,000 (4.42%) | -$34,779,000 (0.56%) | -$34,976,000 (-128.83%) |
Enterprise Value (EV) | $32,916,271 (-17.71%) | $40,001,395 (14.42%) | $34,959,069 (-46.70%) | $65,595,186 (-20.46%) |
Earnings Before Tax (EBT) | -$38,492,000 (6.80%) | -$41,300,000 (12.97%) | -$47,454,000 (9.77%) | -$52,595,000 (-55.57%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$35,903,000 (-10.37%) | -$32,530,000 (-0.28%) | -$32,439,000 (23.42%) | -$42,361,000 (-47.41%) |
Invested Capital | $43,766,000 (-7.44%) | $47,285,000 (96.72%) | $24,037,000 (-12.46%) | $27,457,000 (104.81%) |
Working Capital | $12,494,000 (-10.60%) | $13,976,000 (274.31%) | -$8,018,000 (-161.85%) | $12,963,000 (183.53%) |
Tangible Asset Value | $34,946,000 (14.03%) | $30,647,000 (22.54%) | $25,010,000 (-18.31%) | $30,614,000 (65.43%) |
Market Capitalization | $11,916,271 (55.07%) | $7,684,395 (-39.11%) | $12,621,069 (-74.83%) | $50,140,186 (-32.59%) |
Average Equity | $12,450,250 (157.93%) | $4,827,000 (40.44%) | $3,437,000 (-85.80%) | $24,209,750 (195.38%) |
Average Assets | $57,184,750 (11.45%) | $51,310,500 (1.84%) | $50,381,750 (-19.64%) | $62,693,000 (67.26%) |
Invested Capital Average | $41,292,000 (17.89%) | $35,025,500 (36.38%) | $25,681,750 (-14.88%) | $30,171,750 (10780.27%) |
Shares | 471,932 (-99.07%) | 50,755,580 (2521.08%) | 1,936,441 (201.25%) | 642,807 (58.48%) |
